Protea Biosciences Group Financials

Protea Biosciences Stock Summary

Protea Biosciences competes with U Haul, Fortress Transp, FTAI Aviation, Reservoir Media, and Herc Holdings. Protea Biosciences Group, Inc., a molecular information company, develops and commercializes proprietary life science technologies, products, and services to identify the molecules that are produced by living cells and various life forms.

Protea Biosciences Key Financial Ratios

Generally speaking, Protea Biosciences' financial ratios allow both analysts and investors to convert raw data from Protea Biosciences' financial statements into concise, actionable information that can be used to evaluate the performance of Protea Biosciences over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Protea Biosciences reports annually and quarterly.

Protea Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Protea Biosciences's current stock value. Our valuation model uses many indicators to compare Protea Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Protea Biosciences competition to find correlations between indicators driving Protea Biosciences's intrinsic value. More Info.Protea Biosciences Group is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Protea Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Protea Biosciences' OTC BB Equity. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Protea Biosciences' earnings, one of the primary drivers of an investment's value.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Protea Biosciences information on this page should be used as a complementary analysis to other Protea Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

If you are still planning to invest in Protea Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Protea Biosciences' history and understand the potential risks before investing.